Dupilumab as a rescue therapy for a chronic urticaria patient who showed secondary failure to omalizumab
Author:
Affiliation:
1. Department of Dermatology Kaohsiung Medical University Hospital Kaohsiung Taiwan
2. Department of Dermatology, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan
Publisher
Wiley
Subject
General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12531
Reference5 articles.
1. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
2. Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020
3. Autoimmune chronic spontaneous urticaria: What we know and what we do not know
4. Dupilumab in dermatology: potential for uses beyond atopic dermatitis;Maloney NJ;J Drugs Dermatol,2019
5. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials;Journal of Allergy and Clinical Immunology;2024-07
2. Omalizumab-induced paradoxical urticaria responsive to dupilumab;Annales de Dermatologie et de Vénéréologie;2023-12
3. Dupilumab in Inflammatory Skin Diseases: A Systematic Review;Biomolecules;2023-03-31
4. Case report: Severe chronic spontaneous urticaria successfully treated with omalizumab and dupilumab;Allergologie select;2023-01-01
5. Antihistamines/ciclosporin;Reactions Weekly;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3